[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588861":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":26,"locations":32,"responsibleParty":51,"collaborators":25,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":25,"overallStatus":35,"whyStopped":25,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Kafrelsheikh University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Misoprostol before elective cesarean section .","ACTIVE_COMPARATOR","candidates will receive 100mcg Misoprostol one hour before elective caesarean section.",[13],"Drug: Misoprostol",{"label":15,"type":16,"description":17,"interventionNames":18},"Giving no treatment before elective caesarean section.","PLACEBO_COMPARATOR","candidates will receive no treatment before elective caesarean section.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Misoprostol","administration of 100mg of misoprostol to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.",[15,9],null,[27],{"name":28,"role":29,"phone":30,"phoneExt":25,"email":31},"Merna Ashraf Ahmed farid, M.B.B.C.H","CONTACT","01093030236","mernaashraf2551996@gmail.com",[33],{"facility":34,"status":35,"city":36,"state":25,"zip":25,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Kafr El-sheikh University Hospital","RECRUITING","Kafr Ash Shaykh, Egypt","Egypt","EG",{"type":40,"coordinates":41},"Point",[42,43],30.93991,31.11174,{"lat":43,"lon":42},[46,48],{"name":47,"role":29,"phone":30,"phoneExt":25,"email":31},"Merna Ashraf Ahmed Farid, M.B.B.C.H",{"name":49,"role":29,"phone":50,"phoneExt":25,"email":25},"mostafa farag ellkany, MD","01016083210",{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Merna Ashraf Ahmed Farid","gynaecologist and obsteterician resident","100588861","phase-4-misoprostol-before-caesarean-section-100588861",false,"NCT06946914","Misoprostol Before Caesarean Section","Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns","Miso\u002FCS","Inclusion Criteria:\n\n* Women with indication for elective caesarean section.\n* Age less than 35 years old.\n* Gestational age less than 38 weeks.\n* Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.\n* Singleton pregnancy with no major anomalies\n\nExclusion Criteria:\n\n* Any obstetric disorders as preeclampsia and diabetes.\n* Fetus with oligohydramnios, intrauterine growth restriction.\n* Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia.\n* History of more than or equal 2 previous caesarean section.",true,"FEMALE","20 Years","35 Years",{"count":68,"type":69},160,"ESTIMATED","INTERVENTIONAL",[72],"PHASE4","The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.",[22,75,76],"Respiratory Distress Syndrome (RDS) of Neonate","Caesarean Section","2025-05-08",{"date":79,"type":80},"2025-05-13","ACTUAL",{"date":82,"type":80},"2024-06-01",{"date":84,"type":69},"2025-08-01",{"name":5,"class":6},1]